Growing community of inventors

Geneva, Switzerland

Justyna Iwaszkiewicz

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 6

Justyna IwaszkiewiczMartine Cerutti (4 patents)Justyna IwaszkiewiczJean Kadouche (4 patents)Justyna IwaszkiewiczVincent Zoete (4 patents)Justyna IwaszkiewiczJean-Pierre Mach (4 patents)Justyna IwaszkiewiczOlivier Michielin (4 patents)Justyna IwaszkiewiczSylvie Choblet (4 patents)Justyna IwaszkiewiczJosee Golay (4 patents)Justyna IwaszkiewiczMartine Cerutti (2 patents)Justyna IwaszkiewiczJosée Golay (0 patent)Justyna IwaszkiewiczJustyna Iwaszkiewicz (4 patents)Martine CeruttiMartine Cerutti (12 patents)Jean KadoucheJean Kadouche (8 patents)Vincent ZoeteVincent Zoete (7 patents)Jean-Pierre MachJean-Pierre Mach (6 patents)Olivier MichielinOlivier Michielin (5 patents)Sylvie ChobletSylvie Choblet (4 patents)Josee GolayJosee Golay (4 patents)Martine CeruttiMartine Cerutti (3 patents)Josée GolayJosée Golay (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Centre National De La Recherche Scientifique (4 from 5,072 patents)

2. UniversitÉ De Lausanne (3 from 23 patents)

3. Other (2 from 832,718 patents)

4. Azienda Socio Sanitaria Territoriale Papa Giovanni Xxiii (2 from 2 patents)

5. University of Lausanne (1 from 8 patents)

6. Azienda Ospedaliera Papa Giovanni Xxiii (1 from 1 patent)

7. Jean Kadouche (1 from 1 patent)

8. Kadouche, Jean (0 patent)


4 patents:

1. 12378325 - Multispecific antigens binding fragments and multspecific antibodies

2. 11945879 - Multispecific antigens binding fragments and multispecific antibodies

3. 10815310 - Multispecific antigen binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-kappa domains

4. 9631031 - Multispecific antigens binding fragments and multispecific antibodies derived therefrom comprising mutant CH1 and CL-κ domains

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/13/2025
Loading…